Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

× No keyword cloud information.

20 in total

Review 1. Advances in the medical management of acute coronary syndromes.

Authors: C P Cannon
Journal: J Thromb Thrombolysis Date: 1999-04 Impact factor: 2.300

2. Bleeding incidence after oral surgery with continued oral anticoagulation.

Authors: Wolfgang Eichhorn; Jens Burkert; Oliver Vorwig; Marco Blessmann; Georg Cachovan; Jürgen Zeuch; Marc Eichhorn; Max Heiland
Journal: Clin Oral Investig Date: 2011-12-13 Impact factor: 3.573

3. Deep Vein Thrombosis.

Authors:
Journal: Curr Treat Options Cardiovasc Med Date: 1999-06

4. Activated protein C resistance in central retinal vein occlusion.

Authors: G Sanborn
Journal: Br J Ophthalmol Date: 1996-12 Impact factor: 4.638

5. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal: Circulation Date: 2014-03-28 Impact factor: 29.690

10. Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

Authors: J Jaime Caro; Denis Getsios; Ingrid Caro; Judith A O'Brien
Journal: Pharmacoeconomics Date: 2002 Impact factor: 4.981

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Review 1. Advances in the medical management of acute coronary syndromes.

2. Bleeding incidence after oral surgery with continued oral anticoagulation.

3. Deep Vein Thrombosis.

4. Activated protein C resistance in central retinal vein occlusion.

5. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

6. Evaluation of coagulant activity after mechanical heart valve replacement.

7. Initiation of warfarin therapy: recommendations and clinical pearls.

8. Management of Anticoagulation for Gastrointestinal Endoscopic Procedures.

Review 9. Current guidelines for the treatment of congestive heart failure.

10. Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.